Projekte unter der Sponsorschaft der AIO-Studien-gGmbH

Kolorektales Karzinom

AIO-KRK-0109:  An open-label 2:1 randomized phase I/II study of panitumumab plus FOLFOXIRI or FOLFOXIRI alone as first line treatment of patients with non-resectable metastatic colorectal cancer and RAS wild type (VOLFI)
 
AIO-KRK-0212: Randomized phase II study for evaluation of efficacy and safety of maintenance treatment with 5-FU/FA plus panitumumab vs. 5-FU/FA alone after prior induction treatment with mFOLFOX6 plus panitumumab and re-induction with mFOLFOX6 plus panitumumab in case of progression for first-line treatment of patients with metastatic colorectal cancer (PanaMa)
clinicaltrials.gov
 
AIO-KRK-0214: mFOLFOX6 vs. mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial